---
title: Age dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus
  and gastroesophageal junction - a multicenter retrospective observational study
  of young versus old patients
date: '2023-09-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37720939/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230918181003&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Old patients benefit less from neoadjuvant treatment compared
  to younger patients in terms of gain in overall survival. Since they also experience
  more side effects requiring dose reduction, upfront surgery should be considered
  as the primary treatment option in elderly ...'
disable_comments: true
---
CONCLUSION: Old patients benefit less from neoadjuvant treatment compared to younger patients in terms of gain in overall survival. Since they also experience more side effects requiring dose reduction, upfront surgery should be considered as the primary treatment option in elderly ...